ABAndreas Beckmann

Andreas Beckmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andreas Beckmann has a total of 110 co-authors. Here are the top co-authors by number of shared publications:

  • Renate Meyer

    BQS Institute for Quality and Patient Safety, Germany

    10 shared publications
  • Jana Lewandowski

    German Society for Thoracic and Cardiovascular Surgery, Langenbeck-Virchow-Haus, Berlin, Germany

    8 shared publications
  • Andreas Markewitz

    German Society for Thoracic and Cardiovascular Surgery, Langenbeck-Virchow-Haus, Berlin, Germany

    7 shared publications
  • Jan Gummert

    Heart and Diabetes Center Northrhine Westfalia, Nordrhein-Westfalen, Germany

    6 shared publications
  • Volkmar Falk

    Department for Cardiac, Thoracic and Vascular Surgery, German Heart Center Charité, University Medicine, Germany

    4 shared publications
  • Michael Frie

    FOM Hochschule fuer Oekonomie & Management, Essen, Germany

    3 shared publications

Latest Publications

  • German Heart Surgery Report 2025: The Annual Updated Registry of the German Society for Thoracic and Cardiovascular Surgery

    by Andreas Beckmann, Renate Meyer, Inge König, Jan Gummert, Torsten Doenst

    Based on a voluntary registry, founded by the German Society for Thoracic and Cardiovascular Surgery (DGTHG) in 1980, well-defined but limited datasets of all cardiac and vascular surgery procedures performed in 78 German heart surgery departments are reported annually. For the year 2025, nearly all departments submitted a total of 181,988 procedures to the registry. Of these operations, 107,546 are defined as heart surgery procedures in a classical sense. The unadjusted in-hospital survival rate for the 29,267 isolated coronary artery bypass grafting (CABG) procedures (relationship on-/off-pump 2.4:1) was 97.7%, 97.4% for the 48,167 isolated heart valve procedures (26,896 transcatheter interventions included) and 99.3% for 19,528 pacemaker/implantable cardioverter defibrillator (ICD) procedures, respectively. Concerning short- and long-term mechanical circulatory support, a total of 3,109 ECLS/ECMO implantations and 867 ventricular assist device implantations (L-/R-/BVAD, TAH) were reported. In 2025, 358 isolated heart transplantations, 310 isolated lung transplantations, and 6 combined heart–lung transplantations were performed. This annually updated registry of the DGTHG represents non-risk adjusted voluntary public reporting, encompassing actual data for nearly all heart surgical procedures in Germany, indicating trends in heart medicine, and representing a basis for quality management (e.g., benchmark) for all participating institutions.

  • German Heart Surgery Report 2024: The Annual Updated Registry of the German Society for Thoracic and Cardiovascular Surgery

    by Andreas Beckmann, Renate Meyer, Jana Eberhardt, Jan Gummert, Volkmar Falk

    Based on a voluntary registry, founded by the German Society for Thoracic and Cardiovascular Surgery (DGTHG) in 1980, well-defined but limited datasets of all cardiac and vascular surgery procedures performed in 77 German heart surgery departments are reported annually. For the year 2024, a total of 178,547 procedures were submitted to the registry. A total of 103,617 of these operations are defined as heart surgery procedures in a classical sense. The unadjusted in-hospital survival rate for the 28,843 isolated coronary artery bypass grafting procedures (relationship on-/off-pump 2.5:1) was 97.8%. A total of 97.2% for the 45,422 isolated heart valve procedures (24,957 transcatheter interventions included) and 99.3% for 20,114 pacemaker/implantable cardioverter defibrillator procedures, respectively. Concerning short- and long-term mechanical circulatory support, a total of 3,168 extracorporeal life support/extracorporeal membrane oxygenation implantations, and 809 ventricular assist device implantations (L-/R-/biventricular assist device, total artificial heart) were reported. In 2024, 348 isolated heart transplantations, 287 isolated lung transplantations, and 2 combined heart–lung transplantations were performed. This annually updated registry of the DGTHG represents nonrisk-adjusted voluntary public reporting encompasses actual data for nearly all heart surgical procedures in Germany, constitutes trends in heart medicine, and represents a basis for quality management (e.g., benchmark) for all participating institutions.


  • “End-of-Life Care” in Cardiac Surgery

    by Artur Lichtenberg, Max Scherner, Stefan Meier, Moritz Blum, Markus Krane, Torsten Doenst, Andreas Beckmann, Volkmar Falk

    Modern cardiovascular medicine and surgery enable the treatment of complex cardiovascular disease, even in elderly and multimorbid patients, through increasingly sophisticated procedures. Nevertheless, there are situations in which surgical intervention appears medically inappropriate or is explicitly declined by the patient. Similarly, it may become necessary in the postoperative course to revise the original therapeutic goals—particularly when continued survival depends upon prolonged intensive care unit treatment, or when the anticipated quality of life, from the patient's perspective, appears inadequate. While established guidelines and position papers—most notably from the German Interdisciplinary Association for Intensive and Emergency Medicine—are already available in the field of intensive care medicine (33, 46), a discipline-specific framework for cardiac surgery has been lacking thus far. This inaugural position paper issued by the German Society for Thoracic and Cardiovascular Surgery seeks to contribute to the definition of clinical and ethical standards in the context of therapeutic restraint (Section A) and to the redefinition of therapeutic goals (Section B) within our specialty. The aim is to promote a structured and multiprofessional approach that transparently integrates the core pillars of goal setting in therapy—namely, medical indication and patient autonomy—into a comprehensible decision-making framework. Achieving this objective requires close collaboration among physicians and nursing staff in cardiac surgery, cardiology, intensive care, anesthesiology, ethics consultation, and palliative care. The present recommendations are intended to serve as a foundation for patient-centered, appropriate, and transparent decision-making—always with the overarching aim of preserving the dignity and self-determination of the patients concerned. * These authors share equal first authorship of this article. Received: 31 July 2025 Accepted: 18 August 2025 Article published online: 11 November 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany


  • Diagnosis-Driven, Cross-Disciplinary QA System for Coronary Artery Disease—Study Protocol

    by Fakhrah Maryam Iqbal, Max Geraedts, Limei Ji, Volkmar Falk, Torsten Doenst, Stefan Blankenberg, Patrick Diemert, Klaus Döbler, Christian Günster, Andreas Beckmann

    Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are invasive treatment options for coronary artery disease (CAD), aiming to improve quality of life and reduce cardiovascular morbidity and mortality. Guidelines-based revascularization decisions should consider anatomical complexity, comorbidities, and patient preferences, with procedural risk assessed through validated scoring systems. However, the current legal quality assurance (QA) programs in Germany remain procedure specific and therefore lack a patient-centered, diagnosis-oriented approach. This study proposes a paradigm shift toward diagnosis-based QA to optimize individualized treatment selection, improve outcome attribution, and ensure transparent quality assessment. By integrating guideline recommendations with enhanced data linkage, this framework aims to standardize and improve CAD care quality while addressing limitations of existing QA schemes.This mixed-methods study aims to develop a cross-disciplinary QA framework for CAD patients undergoing elective PCI or CABG. Qualitative methods will be employed to formulate preliminary evidence-based quality indicators (QI), while secondary data analyses will provide empirical support for QI prioritization, modeling, and future evaluation. Findings from both approaches will undergo a structured consensus process to establish validated QI as basis of a redesigned QA scheme.The resulting framework seeks to standardize and improve QA procedures across CAD care pathways, integrating clinical expertise with real-world data to enhance patient outcome.The study proposes a patient-centered, diagnosis-based quality assurance framework for coronary artery disease care, aiming to improve treatment decisions and outcomes. By integrating guideline, expert input, and real-world data, it seeks to enhance transparency and standardization in quality assessment across CAD treatment pathways.

  • Open Access

    Radiation Exposure during Cardiac Interventions in Congenital Heart Defects: A Multicenter German Registry Analysis 2012–2020

    by Anja Tengler, Jörg Michel, Claudia Arenz, Uirike Bauer, Jens Beudt, Alexander Horke, Gunter Kerst, Andreas Beckmann, Michael Hofbeck

    Background Interventional cardiac catheterizations have gained major importance in the treatment of congenital heart defects (CHDs). Since patients with CHDs frequently require lifelong medical care and sometimes subsequent invasive treatment, repeated radiation exposure during interventional procedures is a relevant issue concerning potential radiation-related risks. Therefore, a 9-year subanalysis on radiation data during interventional cardiac catheterizations from the German Registry for Cardiac Operations and Interventions in patients with CHDs was performed. Methods The German Registry for Cardiac Operations and Interventions in Patients with CHDs is a real-world, prospective all-comers database collecting clinical and procedural data on invasive treatment of CHDs. From January 2012 until December 2020, a total of 28,374 cardiac catheter interventions were recorded. For a homogeneous case mix and for obtaining comparable data, eight specified interventions were selected for detailed evaluation. The selected procedures were: atrial septal defect (ASD)/patent foramen ovale (PFO) occlusion, patent ductus arteriosus (PDA) occlusion, ventricular septal defect (VSD) occlusion, coarctation of the aorta (CoA) balloon dilatation and stent implantation, aortic valvuloplasty, pulmonary valvuloplasty, and transcatheter pulmonary valve implantation (TPVI). Data on radiation exposure included total fluoroscopy time (TFT), dose area product (DAP), and DAP per body weight (DAP/BW). Results The cohort accounted for 9,350 procedures, including 3,426 ASD/PFO occlusions, 2,039 PDA occlusions, 599 aortic and 1,536 pulmonary valvuloplasties, 383 balloon dilatations and 496 stent implantations for CoA, 168 VSD occlusions, and 703 TPVI. Six hundred and ten ASD/PFO procedures (17.8%) were performed without radiation. During the 9-year period, median annual TFT, DAP, and DAP/BW showed a continuous decrease while radiation burden correlated with intervention complexity: For ASD/PFO and PDA occlusion, aortic and pulmonary valvuloplasty as well as balloon dilatation of CoA the median DAP/BW was 2/kg, while median values of 26.3 μGy*m2/kg and 31.6 μGy*m2/kg were noted for stent treatment of CoA and VSD closure, respectively. Radiation burden was highest in TPVI with a median TFT of 23.6 minutes, median DAP of 4,491 μGy*m2, and median DAP/BW of 79.4 μGy*m2/kg. Conclusion A decrease in radiation exposure was found in eight cardiac interventions from January 2012 to December 2020. Comparison with international registries revealed a good quality of radiation protection. The data underline the requirement of surveillance of radiation burden, especially in this patient group. Received: 25 November 2024 Accepted: 10 January 2025 Accepted Manuscript online: 13 January 2025 Article published online: 04 March 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany


  • German Heart Surgery Report 2023: The Annual Updated Registry of the German Society for Thoracic and Cardiovascular Surgery

    by Andreas Beckmann, Renate Meyer, Jana Eberhardt, Jan Gummert, Volkmar Falk

    Based on a voluntary registry, founded by the German Society for Thoracic and Cardiovascular Surgery (DGTHG) in 1980, a well-defined but limited dataset of all cardiac and vascular surgery procedures performed in 77 German heart surgery departments is reported annually. For the year 2023, a total of 168,841 procedures were submitted to the registry. Of these operations, 100,606 are defined as heart surgery procedures in a classical sense. The unadjusted in-hospital survival rate for the 28,996 isolated coronary artery bypass grafting procedures (relationship on-/off-pump 2.8:1) was 97.6%; 97.7% for the 39,859 isolated heart valve procedures (23,727 transcatheter interventions included); and 99.2% for 19,699 pacemaker/implantable cardioverter defibrillator procedures. Concerning short and long-term mechanical circulatory support, a total of 2,982 extracorporeal life support/extracorporeal membrane oxygenation implantations and 772 ventricular assist device implantations (left/right ventricular assist device, BVAD, total artificial heart) were reported. In 2023, 324 isolated heart transplantations, 248 isolated lung transplantations, and 2 combined heart–lung transplantations were performed. This annually updated registry of the DGTHG represents nonrisk adjusted voluntary public reporting and encompasses acute data for nearly all heart surgical procedures in Germany. It constitutes trends in heart medicine and represents a basis for quality management (e.g., benchmark) for all participating institutions.


  • Open Access

    German Registry for Cardiac Operations and Interventions in Congenital Heart Disease: Annual Report 2022

    by Michael Hofbeck, Claudia Arenz, Ulrike M. M. Bauer, Alexander Horke, Gunter Kerst, Renate Meyer, Anja Tengler, Andreas Beckmann

    Background The German Registry for Cardiac Operations and Interventions in Patients with Congenital Heart Disease is a voluntary registry initiated by the German Society for Thoracic and Cardiovascular Surgery and the German Society for Pediatric Cardiology and Congenital Heart Defects. Since 2012, the registry collects data for the assessment of treatment and outcomes of surgical and interventional procedures in patients with congenital heart disease (CHD) of all age groups. Methods This real-world, prospective all-comers registry collects clinical and procedural characteristics, adverse events (AEs), mortality, and medium-term outcomes (up to 90 days) of patients undergoing surgical and interventional. A unique pseudonymous personal identifier (PID) allows longitudinal data acquisition in case of further invasive treatment in any participating German heart center. Prior to evaluation, all data sets are monitored for data completeness and integrity. Evaluation includes risk stratification of interventional and surgical procedures and classification of AEs. Each year's data are summarized in annual reports containing detailed information on the entire cohort, all subgroups, and 15 index procedures. In addition, each participating center receives an institutional benchmark report for comparison with the national results. This paper presents a comprehensive summary of the annual report 2021. Results In 2021, a total of 5,439 patients were included by 22 participating centers. In total, 3,721 surgical, 3,413 interventional, and 34 hybrid procedures were performed during 6,122 hospital stays. 2,220 cases (36.3%) could be allocated to the 15 index procedures. The mean unadjusted in-hospital mortality ranged from 0.4% among interventional and 2% among surgical cases up to 6.2 % in cases with multiple procedures. In-hospital mortality among index procedures accounted for 2.3% in total cavopulmonary connection, 20.3% in Norwood procedures, and 0.4% following interventional closure of patent ductus arteriosus. For the remaining seven surgical and five interventional index procedures, no in-hospital deaths were recorded. The 10-year longitudinal evaluation of 1,795 patients after tetralogy of Fallot repair revealed repeat interventional or surgical procedures in 21% of the patients. Over the same period, 31.1% of 2,037 patients, following initial treatment of native coarctation, required at least one additional hospital admission, 39.4% after initial interventional, and 21.3% after initial surgical therapy. Conclusion The annual report 2021 of the German Registry for Cardiac Operations and Interventions in CHD shows continuously good results in accordance with previous data of the registry. Compared to international registries on CHD, it can be ascertained that in Germany invasive treatment of CHD is offered on a high medical level with excellent quality. The proven fact that patients with various malformations like tetralogy of Fallot and coarctation of the aorta require repeat procedures during follow-up confirms the urgent requirement for longitudinal assessment of all patients presenting with complex lesions.


  • German Heart Surgery Report 2022: The Annual Updated Registry of the German Society for Thoracic and Cardiovascular Surgery

    by Andreas Beckmann, Renate Meyer, Jana Lewandowski, Andreas Markewitz, Daniela Blaßfeld, Andreas Böning

    Based on a longtime voluntary registry, founded by the German Society for Thoracic and Cardiovascular Surgery (GSTCVS/DGTHG) in 1980, well-defined data of all cardiac, thoracic, and vascular surgery procedures performed in 78 German heart surgery departments during the year 2022 are analyzed. Under the decreasing interference of the worldwide coronavirus disease 2019 pandemic, a total of 162,167 procedures were submitted to the registry. A total of 93,913 of these operations are summarized as heart surgery procedures in a classical sense. The unadjusted in-hospital survival rate for the 27,994 isolated coronary artery bypass grafting procedures (relationship on-/off-pump 3.2:1) was 97.5%. For the 38,492 isolated heart valve procedures (20,272 transcatheter interventions included) it was 96.9%, and for the registered pacemaker/implantable cardioverter-defibrillator procedures (19,531) 99.1%, respectively. Concerning short- and long-term circulatory support, a total of 2,737 extracorporeal life support/extracorporeal membrane oxygenation implantations, respectively 672 assist device implantations (L-/ R-/ BVAD, TAH) were registered. In 2022, 356 isolated heart transplantations, 228 isolated lung transplantations, and 5 combined heart-lung transplantations were performed. This annually updated registry of the GSTCVS/DGTHG represents voluntary public reporting by accumulating actual information for nearly all heart surgical procedures in Germany, constitutes advancements in heart medicine, and represents a basis for quality management for all participating institutions. In addition, the registry demonstrates that the provision of cardiac surgery in Germany is up to date, appropriate, and nationwide patient treatment is always available.


  • TAVI With or Without Predilation: Trends From a Large, Propensity-Score Weighted German Aortic Valve Registry (GARY) Population

    by Brunilda Alushi, Alexander Lauten, Umniye Balaban, Eva Herrmann, Andreas Schaefer, Timm Bauer, Andreas Beckmann, Sabine Bleiziffer, Christian Frerker, Helge Möllmann, et al.

    Currently, it is unclear whether transcatheter aortic valve implantation (TAVI) without predilation (direct TAVI; d-TAVI) or with preimplantation balloon valvuloplasty (b-TAVI) provides similar clinical safety and efficacy. Therefore, we analyzed patients undergoing d-TAVI or b-TAVI for severe aortic stenosis (AS) with either self-expanding or balloon-expandable transcatheter heart valves (THVs) from the German Aortic Valve Registry (GARY). Original Contribution from Journal of Invasive Cardiology. TAVI predilation self-expanding valve balloon-expanding valve


  • A Novel Model to Predict 1-Year Mortality in Elective Transfemoral Aortic Valve Replacement: The TAVR-Risk Score

    by Christian Jung, Buntaro Fujita, Kari Feldt, Berhnard Wernly, Raphael Romano Bruno, Georg Wolff, Tobias Zeus, Amin Polzin, Artur Lichtenberg, Friedhelm Beyersdorf, et al.

    The authors aimed to develop an effective prediction model for 1-year mortality risk in elective transfemoral transcatheter aortic valve replacement, ie, the TAVR-Risk (TARI) model.